Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease
Sponsor
Boehringer Ingelheim (Industry)
Overall Status
Completed
CT.gov ID
NCT00752388
Collaborator
(none)
1,588
278
5.7
Study Details
Study Description
Brief Summary
To assess the predictive value of sequential administration of WHO-5 and MDI (Major Depression Inventory) for the clinical management of Parkinson Disease (PD) patients by
-
determination of the prevalence of depression in PD patients, based on MDI severity categories and the self-rating scale WHO-5, where poor well being was indicated.
-
exploration of influencing factors (PD status, therapeutic status) on the prevalence of MDI depression categories.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
1588 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Application of the WHO-5 Well-being Index (WHO-5) as a Screening Instrument for Depression in Parkinson's Disease
Study Start Date
:
Nov 1, 2008
Actual Primary Completion Date
:
Nov 1, 2008
Outcome Measures
Primary Outcome Measures
- Prevalence of patients with depressive symptoms (based on WHO-5 and MDI) in total and in subgroups [day 1]
Secondary Outcome Measures
- WHO-5 score and items [day 1]
- MDI score (for a subgroup of patients with WHO-5 score < 13 or any WHO-5 item rated with 0 or 1) [day 1]
- Correlation of WHO-5 and MDI (for a subgroup of patients with a WHO-5 score < 13 or any WHO-5 item rated with 0 or 1) in PD patients [day 1]
- Investigator assessment of the applicability of the WHO-5 for screening for depression in PD patients [day 1]
Eligibility Criteria
Criteria
Ages Eligible for Study:
30 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
PD patients attending one of the participating neurologist practices during 2 fixed weeks in November 2008
-
Idiopathic PD with or without fluctuations
-
Male or female PD patients aged at least 30
-
Ability to reliably complete self-rating scales (WHO-5, MDI) ), according to the physician's judgement.
-
Written informed consent by the patient for study participation.
Exclusion Criteria:
-
PD Patients who only attend the practice to get a prescription and are not seen by the doctor on that day
-
Patients who are not able to understand the questionnaires (e.g. due to mental impairment or language problems).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Boehringer Ingelheim Investigational Site 1 | Achim | Germany | ||
| 2 | Boehringer Ingelheim Investigational Site 2 | Achim | Germany | ||
| 3 | Boehringer Ingelheim Investigational Site | Altenburg | Germany | ||
| 4 | Boehringer Ingelheim Investigational Site | Altenholz | Germany | ||
| 5 | Boehringer Ingelheim Investigational Site | Alzey | Germany | ||
| 6 | Boehringer Ingelheim Investigational Site | Aue | Germany | ||
| 7 | Boehringer Ingelheim Investigational Site | Bad Driburg | Germany | ||
| 8 | Boehringer Ingelheim Investigational Site | Bad Homburg | Germany | ||
| 9 | Boehringer Ingelheim Investigational Site | Bad Honnef | Germany | ||
| 10 | Boehringer Ingelheim Investigational Site | Bad Neuenahr-Ahrweiler | Germany | ||
| 11 | Boehringer Ingelheim Investigational Site 1 | Bad Soden | Germany | ||
| 12 | Boehringer Ingelheim Investigational Site 2 | Bad Soden | Germany | ||
| 13 | Boehringer Ingelheim Investigational Site | Bad Sooden-Allendorf | Germany | ||
| 14 | Boehringer Ingelheim Investigational Site | Bergisch Gladbach | Germany | ||
| 15 | Boehringer Ingelheim Investigational Site 10 | Berlin | Germany | ||
| 16 | Boehringer Ingelheim Investigational Site 11 | Berlin | Germany | ||
| 17 | Boehringer Ingelheim Investigational Site 12 | Berlin | Germany | ||
| 18 | Boehringer Ingelheim Investigational Site 13 | Berlin | Germany | ||
| 19 | Boehringer Ingelheim Investigational Site 14 | Berlin | Germany | ||
| 20 | Boehringer Ingelheim Investigational Site 1 | Berlin | Germany | ||
| 21 | Boehringer Ingelheim Investigational Site 2 | Berlin | Germany | ||
| 22 | Boehringer Ingelheim Investigational Site 3 | Berlin | Germany | ||
| 23 | Boehringer Ingelheim Investigational Site 4 | Berlin | Germany | ||
| 24 | Boehringer Ingelheim Investigational Site 5 | Berlin | Germany | ||
| 25 | Boehringer Ingelheim Investigational Site 6 | Berlin | Germany | ||
| 26 | Boehringer Ingelheim Investigational Site 7 | Berlin | Germany | ||
| 27 | Boehringer Ingelheim Investigational Site 8 | Berlin | Germany | ||
| 28 | Boehringer Ingelheim Investigational Site 9 | Berlin | Germany | ||
| 29 | Boehringer Ingelheim Investigational Site 1 | Bielefeld | Germany | ||
| 30 | Boehringer Ingelheim Investigational Site 2 | Bielefeld | Germany | ||
| 31 | Boehringer Ingelheim Investigational Site 1 | Bochum | Germany | ||
| 32 | Boehringer Ingelheim Investigational Site 2 | Bochum | Germany | ||
| 33 | Boehringer Ingelheim Investigational Site 3 | Bochum | Germany | ||
| 34 | Boehringer Ingelheim Investigational Site | Bockhorn | Germany | ||
| 35 | Boehringer Ingelheim Investigational Site | Bonn | Germany | ||
| 36 | Boehringer Ingelheim Investigational Site | Braunschweig | Germany | ||
| 37 | Boehringer Ingelheim Investigational Site | Bremen | Germany | ||
| 38 | Boehringer Ingelheim Investigational Site | Bremerhaven | Germany | ||
| 39 | Boehringer Ingelheim Investigational Site | Bretten | Germany | ||
| 40 | Boehringer Ingelheim Investigational Site 1 | Butzbach | Germany | ||
| 41 | Boehringer Ingelheim Investigational Site 2 | Butzbach | Germany | ||
| 42 | Boehringer Ingelheim Investigational Site | Buxtehude | Germany | ||
| 43 | Boehringer Ingelheim Investigational Site | Castrop-Rauxel | Germany | ||
| 44 | Boehringer Ingelheim Investigational Site | Chemnitz | Germany | ||
| 45 | Boehringer Ingelheim Investigational Site | Cloppenburg | Germany | ||
| 46 | Boehringer Ingelheim Investigational Site | Coesfeld | Germany | ||
| 47 | Boehringer Ingelheim Investigational Site 1 | Cottbus | Germany | ||
| 48 | Boehringer Ingelheim Investigational Site 2 | Cottbus | Germany | ||
| 49 | Boehringer Ingelheim Investigational Site | Delmenhorst | Germany | ||
| 50 | Boehringer Ingelheim Investigational Site 1 | Dessau | Germany | ||
| 51 | Boehringer Ingelheim Investigational Site 2 | Dessau | Germany | ||
| 52 | Boehringer Ingelheim Investigational Site | Dietzenbach | Germany | ||
| 53 | Boehringer Ingelheim Investigational Site | Dippoldiswalde | Germany | ||
| 54 | Boehringer Ingelheim Investigational Site 1 | Dortmund | Germany | ||
| 55 | Boehringer Ingelheim Investigational Site 2 | Dortmund | Germany | ||
| 56 | Boehringer Ingelheim Investigational Site 3 | Dortmund | Germany | ||
| 57 | Boehringer Ingelheim Investigational Site 1 | Dresden | Germany | ||
| 58 | Boehringer Ingelheim Investigational Site 2 | Dresden | Germany | ||
| 59 | Boehringer Ingelheim Investigational Site 3 | Dresden | Germany | ||
| 60 | Boehringer Ingelheim Investigational Site 4 | Dresden | Germany | ||
| 61 | Boehringer Ingelheim Investigational Site 1 | Duisburg | Germany | ||
| 62 | Boehringer Ingelheim Investigational Site 2 | Duisburg | Germany | ||
| 63 | Boehringer Ingelheim Investigational Site 3 | Duisburg | Germany | ||
| 64 | Boehringer Ingelheim Investigational Site 4 | Duisburg | Germany | ||
| 65 | Boehringer Ingelheim Investigational Site | Dülmen | Germany | ||
| 66 | Boehringer Ingelheim Investigational Site 1 | Düsseldorf | Germany | ||
| 67 | Boehringer Ingelheim Investigational Site 2 | Düsseldorf | Germany | ||
| 68 | Boehringer Ingelheim Investigational Site 3 | Düsseldorf | Germany | ||
| 69 | Boehringer Ingelheim Investigational Site 4 | Düsseldorf | Germany | ||
| 70 | Boehringer Ingelheim Investigational Site 5 | Düsseldorf | Germany | ||
| 71 | Boehringer Ingelheim Investigational Site 1 | Erbach | Germany | ||
| 72 | Boehringer Ingelheim Investigational Site 2 | Erbach | Germany | ||
| 73 | Boehringer Ingelheim Investigational Site | Erftstadt | Germany | ||
| 74 | Boehringer Ingelheim Investigational Site | Essen | Germany | ||
| 75 | Boehringer Ingelheim Investigational Site 1 | Frankfurt | Germany | ||
| 76 | Boehringer Ingelheim Investigational Site 2 | Frankfurt | Germany | ||
| 77 | Boehringer Ingelheim Investigational Site | Freiburg | Germany | ||
| 78 | Boehringer Ingelheim Investigational Site | Fürstenwalde | Germany | ||
| 79 | Boehringer Ingelheim Investigational Site | Gelnhausen | Germany | ||
| 80 | Boehringer Ingelheim Investigational Site 1 | Gelsenkirchen | Germany | ||
| 81 | Boehringer Ingelheim Investigational Site 2 | Gelsenkirchen | Germany | ||
| 82 | Boehringer Ingelheim Investigational Site | Gengenbach | Germany | ||
| 83 | Boehringer Ingelheim Investigational Site | Gera | Germany | ||
| 84 | Boehringer Ingelheim Investigational Site | Gießen | Germany | ||
| 85 | Boehringer Ingelheim Investigational Site | Gifhorn | Germany | ||
| 86 | Boehringer Ingelheim Investigational Site | Gladenbach | Germany | ||
| 87 | Boehringer Ingelheim Investigational Site | Goch | Germany | ||
| 88 | Boehringer Ingelheim Investigational Site | Grünstadt | Germany | ||
| 89 | Boehringer Ingelheim Investigational Site | Göttingen | Germany | ||
| 90 | Boehringer Ingelheim Investigational Site 1 | Güstrow | Germany | ||
| 91 | Boehringer Ingelheim Investigational Site 2 | Güstrow | Germany | ||
| 92 | Boehringer Ingelheim Investigational Site | Gütersloh | Germany | ||
| 93 | Boehringer Ingelheim Investigational Site 1 | Halle | Germany | ||
| 94 | Boehringer Ingelheim Investigational Site 2 | Halle | Germany | ||
| 95 | Boehringer Ingelheim Investigational Site 3 | Halle | Germany | ||
| 96 | Boehringer Ingelheim Investigational Site 1 | Hamburg | Germany | ||
| 97 | Boehringer Ingelheim Investigational Site 2 | Hamburg | Germany | ||
| 98 | Boehringer Ingelheim Investigational Site 3 | Hamburg | Germany | ||
| 99 | Boehringer Ingelheim Investigational Site 4 | Hamburg | Germany | ||
| 100 | Boehringer Ingelheim Investigational Site 5 | Hamburg | Germany | ||
| 101 | Boehringer Ingelheim Investigational Site | Hameln | Germany | ||
| 102 | Boehringer Ingelheim Investigational Site 1 | Hannover | Germany | ||
| 103 | Boehringer Ingelheim Investigational Site 2 | Hannover | Germany | ||
| 104 | Boehringer Ingelheim Investigational Site 3 | Hannover | Germany | ||
| 105 | Boehringer Ingelheim Investigational Site 4 | Hannover | Germany | ||
| 106 | Boehringer Ingelheim Investigational Site 1 | Heidelberg | Germany | ||
| 107 | Boehringer Ingelheim Investigational Site 2 | Heidelberg | Germany | ||
| 108 | Boehringer Ingelheim Investigational Site | Heilbronn | Germany | ||
| 109 | Boehringer Ingelheim Investigational Site | Hemmoor | Germany | ||
| 110 | Boehringer Ingelheim Investigational Site | Hennigsdorf | Germany | ||
| 111 | Boehringer Ingelheim Investigational Site | Henstedt-Ulzburg | Germany | ||
| 112 | Boehringer Ingelheim Investigational Site | Herborn | Germany | ||
| 113 | Boehringer Ingelheim Investigational Site | Herzberg | Germany | ||
| 114 | Boehringer Ingelheim Investigational Site | Herzogenrath | Germany | ||
| 115 | Boehringer Ingelheim Investigational Site 1 | Hildesheim | Germany | ||
| 116 | Boehringer Ingelheim Investigational Site 2 | Hildesheim | Germany | ||
| 117 | Boehringer Ingelheim Investigational Site 3 | Hildesheim | Germany | ||
| 118 | Boehringer Ingelheim Investigational Site 4 | Hildesheim | Germany | ||
| 119 | Boehringer Ingelheim Investigational Site 5 | Hildesheim | Germany | ||
| 120 | Boehringer Ingelheim Investigational Site | Homburg | Germany | ||
| 121 | Boehringer Ingelheim Investigational Site | Hückelhoven | Germany | ||
| 122 | Boehringer Ingelheim Investigational Site | Hürth | Germany | ||
| 123 | Boehringer Ingelheim Investigational Site 1 | Ilmenau | Germany | ||
| 124 | Boehringer Ingelheim Investigational Site 2 | Ilmenau | Germany | ||
| 125 | Boehringer Ingelheim Investigational Site | Ingelheim | Germany | ||
| 126 | Boehringer Ingelheim Investigational Site | Iserlohn | Germany | ||
| 127 | Boehringer Ingelheim Investigational Site | Itzehoe | Germany | ||
| 128 | Boehringer Ingelheim Investigational Site | Kamen | Germany | ||
| 129 | Boehringer Ingelheim Investigational Site | Kamp-Lintfort | Germany | ||
| 130 | Boehringer Ingelheim Investigational Site | Kandel | Germany | ||
| 131 | Boehringer Ingelheim Investigational Site | Karlstadt | Germany | ||
| 132 | Boehringer Ingelheim Investigational Site 1 | Kassel | Germany | ||
| 133 | Boehringer Ingelheim Investigational Site 2 | Kassel | Germany | ||
| 134 | Boehringer Ingelheim Investigational Site | Kaufbeuren | Germany | ||
| 135 | Boehringer Ingelheim Investigational Site | Kiel | Germany | ||
| 136 | Boehringer Ingelheim Investigational Site | Kleinblittersdorf | Germany | ||
| 137 | Boehringer Ingelheim Investigational Site | Kleve | Germany | ||
| 138 | Boehringer Ingelheim Investigational Site 1 | Köln | Germany | ||
| 139 | Boehringer Ingelheim Investigational Site 2 | Köln | Germany | ||
| 140 | Boehringer Ingelheim Investigational Site 3 | Köln | Germany | ||
| 141 | Boehringer Ingelheim Investigational Site 4 | Köln | Germany | ||
| 142 | Boehringer Ingelheim Investigational Site 5 | Köln | Germany | ||
| 143 | Boehringer Ingelheim Investigational Site 6 | Köln | Germany | ||
| 144 | Boehringer Ingelheim Investigational Site 7 | Köln | Germany | ||
| 145 | Boehringer Ingelheim Investigational Site | Lappersdorf | Germany | ||
| 146 | Boehringer Ingelheim Investigational Site | Lauterbach | Germany | ||
| 147 | Boehringer Ingelheim Investigational Site 1 | Leer | Germany | ||
| 148 | Boehringer Ingelheim Investigational Site 2 | Leer | Germany | ||
| 149 | Boehringer Ingelheim Investigational Site 1 | Leipzig | Germany | ||
| 150 | Boehringer Ingelheim Investigational Site 2 | Leipzig | Germany | ||
| 151 | Boehringer Ingelheim Investigational Site 3 | Leipzig | Germany | ||
| 152 | Boehringer Ingelheim Investigational Site 4 | Leipzig | Germany | ||
| 153 | Boehringer Ingelheim Investigational Site 5 | Leipzig | Germany | ||
| 154 | Boehringer Ingelheim Investigational Site 1 | Leverkusen | Germany | ||
| 155 | Boehringer Ingelheim Investigational Site 2 | Leverkusen | Germany | ||
| 156 | Boehringer Ingelheim Investigational Site | Ludwigsfelde | Germany | ||
| 157 | Boehringer Ingelheim Investigational Site 1 | Ludwigshafen | Germany | ||
| 158 | Boehringer Ingelheim Investigational Site 2 | Ludwigshafen | Germany | ||
| 159 | Boehringer Ingelheim Investigational Site 3 | Ludwigshafen | Germany | ||
| 160 | Boehringer Ingelheim Investigational Site | Ludwigslust | Germany | ||
| 161 | Boehringer Ingelheim Investigational Site | Löbau | Germany | ||
| 162 | Boehringer Ingelheim Investigational Site 1 | Lüdenscheid | Germany | ||
| 163 | Boehringer Ingelheim Investigational Site 2 | Lüdenscheid | Germany | ||
| 164 | Boehringer Ingelheim Investigational Site 3 | Lüdenscheid | Germany | ||
| 165 | Boehringer Ingelheim Investigational Site 4 | Lüdenscheid | Germany | ||
| 166 | Boehringer Ingelheim Investigational Site 5 | Lüdenscheid | Germany | ||
| 167 | Boehringer Ingelheim Investigational Site 1 | Lüneburg | Germany | ||
| 168 | Boehringer Ingelheim Investigational Site 2 | Lüneburg | Germany | ||
| 169 | Boehringer Ingelheim Investigational Site 1 | Lünen | Germany | ||
| 170 | Boehringer Ingelheim Investigational Site 2 | Lünen | Germany | ||
| 171 | Boehringer Ingelheim Investigational Site | Magdeburg | Germany | ||
| 172 | Boehringer Ingelheim Investigational Site | Malente | Germany | ||
| 173 | Boehringer Ingelheim Investigational Site 1 | Mannheim | Germany | ||
| 174 | Boehringer Ingelheim Investigational Site 2 | Mannheim | Germany | ||
| 175 | Boehringer Ingelheim Investigational Site 3 | Mannheim | Germany | ||
| 176 | Boehringer Ingelheim Investigational Site 4 | Mannheim | Germany | ||
| 177 | Boehringer Ingelheim Investigational Site | Markkleeberg | Germany | ||
| 178 | Boehringer Ingelheim Investigational Site | Marl | Germany | ||
| 179 | Boehringer Ingelheim Investigational Site | Memmingen | Germany | ||
| 180 | Boehringer Ingelheim Investigational Site | Menden | Germany | ||
| 181 | Boehringer Ingelheim Investigational Site | Mittweida | Germany | ||
| 182 | Boehringer Ingelheim Investigational Site 1 | Mönchengladbach | Germany | ||
| 183 | Boehringer Ingelheim Investigational Site 2 | Mönchengladbach | Germany | ||
| 184 | Boehringer Ingelheim Investigational Site 3 | Mönchengladbach | Germany | ||
| 185 | Boehringer Ingelheim Investigational Site | Mühlacker | Germany | ||
| 186 | Boehringer Ingelheim Investigational Site 1 | Mülheim | Germany | ||
| 187 | Boehringer Ingelheim Investigational Site 2 | Mülheim | Germany | ||
| 188 | Boehringer Ingelheim Investigational Site 3 | Mülheim | Germany | ||
| 189 | Boehringer Ingelheim Investigational Site 1 | Münster | Germany | ||
| 190 | Boehringer Ingelheim Investigational Site 2 | Münster | Germany | ||
| 191 | Boehringer Ingelheim Investigational Site 3 | Münster | Germany | ||
| 192 | Boehringer Ingelheim Investigational Site | Naumburg | Germany | ||
| 193 | Boehringer Ingelheim Investigational Site | Neubrandenburg | Germany | ||
| 194 | Boehringer Ingelheim Investigational Site | Neuenhagen | Germany | ||
| 195 | Boehringer Ingelheim Investigational Site | Neukirchen-Vluyn | Germany | ||
| 196 | Boehringer Ingelheim Investigational Site | Neumünster | Germany | ||
| 197 | Boehringer Ingelheim Investigational Site | Neustadt | Germany | ||
| 198 | Boehringer Ingelheim Investigational Site | Norden | Germany | ||
| 199 | Boehringer Ingelheim Investigational Site | Nordhorn | Germany | ||
| 200 | Boehringer Ingelheim Investigational Site | Nübel | Germany | ||
| 201 | Boehringer Ingelheim Investigational Site | Oberndorf | Germany | ||
| 202 | Boehringer Ingelheim Investigational Site | Offenbach | Germany | ||
| 203 | Boehringer Ingelheim Investigational Site | Oldenburg | Germany | ||
| 204 | Boehringer Ingelheim Investigational Site | Oranienburg | Germany | ||
| 205 | Boehringer Ingelheim Investigational Site | Oschatz | Germany | ||
| 206 | Boehringer Ingelheim Investigational Site | Osnabrück | Germany | ||
| 207 | Boehringer Ingelheim Investigational Site | Paderborn | Germany | ||
| 208 | Boehringer Ingelheim Investigational Site | Pirmasens | Germany | ||
| 209 | Boehringer Ingelheim Investigational Site | Plauen | Germany | ||
| 210 | Boehringer Ingelheim Investigational Site | Potsdam | Germany | ||
| 211 | Boehringer Ingelheim Investigational Site | Quakenbrück | Germany | ||
| 212 | Boehringer Ingelheim Investigational Site | Rastatt | Germany | ||
| 213 | Boehringer Ingelheim Investigational Site | Rathenow | Germany | ||
| 214 | Boehringer Ingelheim Investigational Site 1 | Regensburg | Germany | ||
| 215 | Boehringer Ingelheim Investigational Site 2 | Regensburg | Germany | ||
| 216 | Boehringer Ingelheim Investigational Site | Remscheid | Germany | ||
| 217 | Boehringer Ingelheim Investigational Site | Rendsburg | Germany | ||
| 218 | Boehringer Ingelheim Investigational Site | Rheine | Germany | ||
| 219 | Boehringer Ingelheim Investigational Site | Ribnitz-Damgarten | Germany | ||
| 220 | Boehringer Ingelheim Investigational Site | Riesa | Germany | ||
| 221 | Boehringer Ingelheim Investigational Site 1 | Rostock | Germany | ||
| 222 | Boehringer Ingelheim Investigational Site 2 | Rostock | Germany | ||
| 223 | Boehringer Ingelheim Investigational Site 3 | Rostock | Germany | ||
| 224 | Boehringer Ingelheim Investigational Site | Rödermark | Germany | ||
| 225 | Boehringer Ingelheim Investigational Site | Rüdersdorf | Germany | ||
| 226 | Boehringer Ingelheim Investigational Site | Rüsselsheim | Germany | ||
| 227 | Boehringer Ingelheim Investigational Site | Salzgitter | Germany | ||
| 228 | Boehringer Ingelheim Investigational Site | Schirgiswalde | Germany | ||
| 229 | Boehringer Ingelheim Investigational Site | Schleiden | Germany | ||
| 230 | Boehringer Ingelheim Investigational Site | Schriesheim | Germany | ||
| 231 | Boehringer Ingelheim Investigational Site | Schwelm | Germany | ||
| 232 | Boehringer Ingelheim Investigational Site 1 | Schwerin | Germany | ||
| 233 | Boehringer Ingelheim Investigational Site 2 | Schwerin | Germany | ||
| 234 | Boehringer Ingelheim Investigational Site | Seeheim-Jugenheim | Germany | ||
| 235 | Boehringer Ingelheim Investigational Site | Senftenberg | Germany | ||
| 236 | Boehringer Ingelheim Investigational Site 1 | Solingen | Germany | ||
| 237 | Boehringer Ingelheim Investigational Site 2 | Solingen | Germany | ||
| 238 | Boehringer Ingelheim Investigational Site 3 | Solingen | Germany | ||
| 239 | Boehringer Ingelheim Investigational Site 1 | Stade | Germany | ||
| 240 | Boehringer Ingelheim Investigational Site 2 | Stade | Germany | ||
| 241 | Boehringer Ingelheim Investigational Site | Stollberg | Germany | ||
| 242 | Boehringer Ingelheim Investigational Site 1 | Stralsund | Germany | ||
| 243 | Boehringer Ingelheim Investigational Site 2 | Stralsund | Germany | ||
| 244 | Boehringer Ingelheim Investigational Site | Strausberg | Germany | ||
| 245 | Boehringer Ingelheim Investigational Site | Sömmerda | Germany | ||
| 246 | Boehringer Ingelheim Investigational Site | Telgte | Germany | ||
| 247 | Boehringer Ingelheim Investigational Site | Teltow | Germany | ||
| 248 | Boehringer Ingelheim Investigational Site | Torgau | Germany | ||
| 249 | Boehringer Ingelheim Investigational Site | Trier | Germany | ||
| 250 | Boehringer Ingelheim Investigational Site | Troisdorf | Germany | ||
| 251 | Boehringer Ingelheim Investigational Site | Vechta | Germany | ||
| 252 | Boehringer Ingelheim Investigational Site 1 | Velen | Germany | ||
| 253 | Boehringer Ingelheim Investigational Site 2 | Velen | Germany | ||
| 254 | Boehringer Ingelheim Investigational Site 1 | Verden | Germany | ||
| 255 | Boehringer Ingelheim Investigational Site 2 | Verden | Germany | ||
| 256 | Boehringer Ingelheim Investigational Site | Viersen | Germany | ||
| 257 | Boehringer Ingelheim Investigational Site | Villingen-Schwenningen | Germany | ||
| 258 | Boehringer Ingelheim Investigational Site | Voerde | Germany | ||
| 259 | Boehringer Ingelheim Investigational Site 1 | Warendorf | Germany | ||
| 260 | Boehringer Ingelheim Investigational Site 2 | Warendorf | Germany | ||
| 261 | Boehringer Ingelheim Investigational Site | Wedel | Germany | ||
| 262 | Boehringer Ingelheim Investigational Site | Weida | Germany | ||
| 263 | Boehringer Ingelheim Investigational Site | Weil am Rhein | Germany | ||
| 264 | Boehringer Ingelheim Investigational Site | Weißenfels | Germany | ||
| 265 | Boehringer Ingelheim Investigational Site | Werdau | Germany | ||
| 266 | Boehringer Ingelheim Investigational Site | Wesseling | Germany | ||
| 267 | Boehringer Ingelheim Investigational Site | Wetzlar | Germany | ||
| 268 | Boehringer Ingelheim Investigational Site | Weyhe | Germany | ||
| 269 | Boehringer Ingelheim Investigational Site 1 | Wismar | Germany | ||
| 270 | Boehringer Ingelheim Investigational Site 2 | Wismar | Germany | ||
| 271 | Boehringer Ingelheim Investigational Site | Wolfratshausen | Germany | ||
| 272 | Boehringer Ingelheim Investigational Site | Wolgast | Germany | ||
| 273 | Boehringer Ingelheim Investigational Site | Wunstorf | Germany | ||
| 274 | Boehringer Ingelheim Investigational Site 1 | Wuppertal | Germany | ||
| 275 | Boehringer Ingelheim Investigational Site 2 | Wuppertal | Germany | ||
| 276 | Boehringer Ingelheim Investigational Site | Würzburg | Germany | ||
| 277 | Boehringer Ingelheim Investigational Site | Zella-Mehlis | Germany | ||
| 278 | Boehringer Ingelheim Investigational Site | Zwickau | Germany |
Sponsors and Collaborators
- Boehringer Ingelheim
Investigators
- Study Chair: Boehringer Ingelheim, Boehringer Ingelheim
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00752388
Other Study ID Numbers:
- 248.658
First Posted:
Sep 15, 2008
Last Update Posted:
Nov 19, 2013
Last Verified:
Nov 1, 2013
Additional relevant MeSH terms: